ArticlePlanta2026
Combined R2R3-MYB transcription factor mutants reveal the regulatory structure of the Arabidopsis thaliana flavonoid biosynthesis pathway.
Article in Planta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative RNA-Seq and Phytochemical Profiling Reveal Year-Dependent Bioactive Variations and Delineate Key Metabolic Pathways inInternational journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MAIN
conclusionComparative metabolic profiling of new genetic multiple flavonoid r2r3-myb mutants show that different types of R2R3-MYBs activate the early flavonoid biosynthesis genes. A revised model for flavonoid biosynthesis in Arabidopsis thaliana is proposed that integrates the regulatory roles of these R2R3-MYBs across early and late biosynthetic steps. Flavonoids are a large group of specialized plant metabolites. Their biosynthesis is mainly transcriptionally regulated by a sophisticated network of different transcription factors from various families, with R2R3-MYB factors being the main determinant of specific flavonoid class formation. The early biosynthetic steps, leading to the formation of non-visible flavonoids, have been proposed to be regulated by three R2R3-MYBs, PRODUCTION OF FLAVONOL GYLCOSIDE1-3 (PFG1-3), while the later biosynthetic steps leading to the formation of visible anthocyanin and proanthocyanidin pigments are reported to be regulated by four R2R3-MYBs, PRODUCTION OF ANTHOCYANIN PIGMENT1-4 (PAP1-4) and TRANSPARENT TESTA2 (TT2), respectively. Several studies have indicated that this model for the transcriptional regulation of flavonoid biosynthesis may be incomplete. To address this issue, especially regarding the regulation of the early biosynthesis genes by PAP1-4 and TT2, we generated several multiple r2r3-myb mutant lines. We characterized the pfg1-3, pfg1-3 tt2 and pfg1-3 pap1-4 mutants and did comparative metabolite profiling. This revealed that only the pfg1-3 tt2 mutant was deficient in proanthocyanidins and only the pfg1-3 pap1-4 mutant was deficient in anthocyanins. We demonstrate that PAP and TT2 R2R3-MYBs are also capable of activating the early biosynthesis genes required for dihydroflavonol formation. Our results provide evidence that the traditional view of distinct branch-specific R2R3-MYB regulators in flavonoid biosynthesis is overly simplistic. We, therefore, propose a revised model for the transcriptional regulation of flavonoid biosynthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.